Upstream Partners


Upstream News

New Wave Endo
“New Wave Endo".”  Upstream Partners

“New Wave Endo".” Upstream Partners

New Wave Endo announces M-Close surgical device

New Wave Endo announced the launch of the M-Close surgical device at the American College of Surgeons Clinical Congress on October 22, 2018. The M-Close multifunction closure device combines targeted anesthesia delivery with the most advanced port closure device for laparoscopic surgery. As of the date of this article, the device is not yet available for sale in the U.S.

The M-Close was conceived of and developed by the late Dr. Manoj B. Patel, a dear friend and colleague of Upstream Partners.

New Wave Endo is run by the same team that founded and ran New Wave Surgical, which was acquired by Covidien in 2014. Read more about the acquisition here.

IAM Strategy 300 for 2018

IAM Strategy 300 for 2018

Mark Chandler was again recognized by Intellectual Asset Magazine as one of the World’s Leading IP Strategists, by being included in the IAM 300 for the tenth straight year. This peer-selected list cites individuals whose key skill-set is working with IP owners to help them maximize the value of their patents, copyrights, trademarks and other rights.

Click here to view the article.

IP Assets in Population Health Management

Upstream Partners helped a health care provider identify and protect its intellectual property (IP) assets in order to recognize, preserve and increase the value of the company’s intangible assets.

Upstream conducted an audit of a non-for-profit company in health care predictive analytics and patient health care programs in order to help the company identify and value its IP assets as well as the data it had produced, and continues to produce, through its analytics and care plans. This included a deep review of proprietary algorithms, data structures and data content.

It is critical that the company protects and prevents its IP from being copied, adopted and leaked which requires identification and cataloguing its IP. It is also critical that this be updated on a regular and periodic basis.

This closely relates to an engagement in the population health management space. Click here to read more.

Evolution Optiks

Evolution Optiks has been recognized by the Founders Forum as one of twenty "disruptive tech companies" in North America. 

"Given our teams stealthy creation of technology over the last 5 1/2 years, the company has now been recognized and chosen as 1 of 20 key "disruptive tech companies" in North America." Chris Hough, CEO and Founder of Evolution Optiks presented at the Founders Forum event in NYC, revealing the company's game-changing platform.

Evolution Optiks is creating the first real seamless solution for Presbyopia (Farsightedness) and removing the need for corrective lenses when using mobile phone screens. The company is venture backed and has developed a personalized visual acuity solution for viewers of mobile devices and automotive display screens.

Click here to view the article.